Miriam Lancaster sought medical treatment for severe back pain but was offered medical assistance in dying before she had received a diagnosis for her condition.
The encounter has become a focal point for critics of Canada’s Medical Assistance in Dying (MAiD) program, who argue that the current framework encourages euthanasia as a substitute for adequate healthcare. Lancaster reported that the suggestion of euthanasia was presented while she was still navigating the healthcare system to determine the cause of her physical suffering.
A member of Parliament has cited Lancaster’s experience in the House of Commons, presenting the case as evidence that the federal government must halt the expansion of the MAiD program. The legislator argued that offering death to a patient who has not yet been diagnosed represents a systemic failure in the duty of care.
The MAiD Framework and Track 2 Patients
Canada’s euthanasia laws were significantly expanded in 2021. Originally, the law required that a person’s natural death be “reasonably foreseeable.” However, following a court challenge, the government introduced a second pathway, known as “Track 2,” which allows individuals with grievous and irremediable medical conditions to access MAiD even if they are not terminally ill.
Under Track 2, patients must undergo a more rigorous assessment process, including a 90-day assessment period in some cases, to ensure that all other reasonable treatment options have been explored. Critics of this expansion argue that the distinction between “irremediable” and “untreated” has become blurred in clinical practice.
Institutional Concerns Over Safeguards
The case of Miriam Lancaster has intensified a debate over whether socio-economic factors and gaps in the healthcare system are influencing MAiD requests. Advocacy groups and some medical professionals have raised concerns that patients may seek euthanasia not because their medical condition is untreatable, but because they lack access to specialized care, palliative support, or adequate housing.
The Canadian government has previously defended the program, stating that the legal framework includes necessary safeguards to protect vulnerable individuals. However, the lack of standardized reporting on the specific reasons patients qualify for Track 2 has led to calls for greater transparency and a comprehensive review of how the law is applied at the provincial level.
Legislative Delays and Future Expansion
The controversy surrounding the program’s application has coincided with a broader political struggle over the expansion of MAiD to include patients whose sole underlying condition is a mental illness. The federal government has delayed the implementation of this expansion multiple times, most recently pushing the start date to March 2027.
Opponents of the mental health expansion argue that psychiatric conditions are often treatable and that offering euthanasia to those with mental illness risks institutionalizing despair rather than providing recovery services.
The Ministry of Health has not issued a specific response to the details of the Lancaster case, while the debate over the 2027 deadline remains a pending item on the legislative calendar.
